scholarly article | Q13442814 |
P2093 | author name string | M Li | |
Q Xu | |||
X Li | |||
C Chen | |||
T Liu | |||
C J Chen | |||
Y Yan | |||
T Song | |||
Z P Chen | |||
C H Zou | |||
S C Zhao | |||
P2860 | cites work | The prevalence of benign prostatic hyperplasia in mainland China: evidence from epidemiological surveys | Q28082321 |
History of aromatase: saga of an important biological mediator and therapeutic target | Q28242399 | ||
Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement | Q29619465 | ||
Mining disease susceptibility genes through SNP analyses and expression profiling using MALDI-TOF mass spectrometry | Q33202394 | ||
Genotyping of sex hormone-related pathways in benign and malignant human prostate tissues: data of a preliminary study | Q33829149 | ||
Aromatase--a brief overview | Q34112633 | ||
Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms: Epidemiology and Risk Factors | Q34176834 | ||
Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis | Q34408679 | ||
Impact of metabolic syndrome on response to medical treatment of benign prostatic hyperplasia | Q34698236 | ||
Metabolic syndrome and benign prostatic hyperplasia: evidence of a potential relationship, hypothesized etiology, and prevention | Q35182377 | ||
Genetic polymorphisms and prostate cancer risk | Q35597290 | ||
Does Metabolic Syndrome or its Components Correlate With Lower Urinary Tract Symptoms in Benign Prostatic Hyperplasia Patients? | Q35957304 | ||
The relationships between metabolic syndrome, erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia | Q35994047 | ||
Human aromatase: cDNA cloning, Southern blot analysis, and assignment of the gene to chromosome 15. | Q36453370 | ||
Polymorphisms in genes involved in androgen pathways as risk factors for prostate cancer | Q37397317 | ||
Benign prostatic hyperplasia: a new metabolic disease of the aging male and its correlation with sexual dysfunctions. | Q37618958 | ||
Estrogen and androgen signaling in the pathogenesis of BPH. | Q37828063 | ||
Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) - focus on the UK. | Q38198262 | ||
Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies | Q38269343 | ||
Relationship between Metabolic Syndrome and Predictors for Clinical Benign Prostatic Hyperplasia Progression and International Prostate Symptom Score in Patients with Moderate to Severe Lower Urinary Tract Symptoms | Q39649569 | ||
Correlation between prostate volume and single nucleotide polymorphisms implicated in the steroid pathway | Q39699530 | ||
Association of polymorphisms in CYP19A1 and CYP3A4 genes with lower urinary tract symptoms, prostate volume, uroflow and PSA in a population-based sample. | Q39928318 | ||
Relative importance of sexuality and quality of life in patients with prostatic symptoms. Results of an international study. | Q41454280 | ||
Letter to the editor: Impact of metabolic syndrome on response to medical treatment of benign prostatic hyperplasia | Q43125882 | ||
The association between polymorphisms in the CYP17 and 5alpha-reductase (SRD5A2) genes and serum androgen concentrations in men. | Q43575799 | ||
Concurrent improvement of the metabolic syndrome and lower urinary tract symptoms upon normalisation of plasma testosterone levels in hypogonadal elderly men. | Q46163361 | ||
Baseline factors as predictors of clinical progression of benign prostatic hyperplasia in men treated with placebo | Q46974519 | ||
Genetic polymorphism in sex hormone metabolism and prostate cancer risk | Q48972970 | ||
Association of metabolic syndrome and benign prostatic hyperplasia in Chinese patients of different age decades. | Q51231420 | ||
Hormone concentration, metabolic disorders and immunoexpression of androgen and estrogen-alpha receptors in men with benign prostatic hyperplasia and testosterone deficiency syndrome | Q61945860 | ||
Gender differences in the regulation of P450 aromatase expression and activity in human adipose tissue | Q74083090 | ||
Effects of aromatase inhibition in hypogonadal older men: a randomized, double-blind, placebo-controlled trial | Q81616161 | ||
P433 | issue | 4 | |
P921 | main subject | prostatic hypertrophy | Q506659 |
metabolic syndrome | Q657193 | ||
P304 | page(s) | 568-578 | |
P577 | publication date | 2018-06-05 | |
P1433 | published in | Andrology | Q26839702 |
P1476 | title | The single nucleotide polymorphism rs700518 is an independent risk factor for metabolic syndrome and benign prostatic hyperplasia (MetS-BPH) | |
P478 | volume | 6 |
Search more.